CTLA4 and melanoma: The side effects of CTLA-4 inhibitors can include fatigue, diarrhea, etc. It was also discovered that the blockade of CTLA-4 for melanoma treatment can induce grade 3 and 4 Immune-Related Adverse Events (IRAEs), including autoimmune damage in the colon, liver, and endocrine glands [25].